Whitehawk Therapeutics (WHWK) Change in Acquisitions & Divestments (2022 - 2026)

Whitehawk Therapeutics (WHWK) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $38.6 million in Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments rose 162.82% year-over-year to $38.6 million in Q1 2026; TTM through Mar 2026 was $83.8 million, a 41.76% increase from a year earlier, with the FY2025 full-year figure at $59.8 million, down 5.51% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $38.6 million, down from $39.8 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for WHWK reached as high as $51.2 million in Q2 2023 and fell as low as $2.0 million in Q3 2025.
• Historically, Change in Acquisitions & Divestments has averaged $23.3 million across 5 years, with a median of $17.1 million in 2023.
• On a YoY basis, Change in Acquisitions & Divestments climbed as much as 198.57% in 2025 and fell as far as 86.86% in 2025.
• Year by year, Change in Acquisitions & Divestments stood at $12.8 million in 2022, then jumped by 44.02% to $18.4 million in 2023, then dropped by 27.47% to $13.3 million in 2024, then surged by 198.57% to $39.8 million in 2025, then fell by 2.89% to $38.6 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $38.6 million in Q1 2026, $39.8 million in Q4 2025, and $2.0 million in Q3 2025.